Lupartumab
Product Specifications
UNSPSC Description
Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of antibody-drug conjugate BAY 1129980[1].
Target Antigen
ADC Antibody
Type
Inhibitory Antibodies
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lupartumab.html
Purity
99.52
Solubility
H2O
Smiles
[Lupartumab]
References & Citations
[1]Willuda J, et al. Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer. Mol Cancer Ther. 2017 May;16(5):893-904.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99718/Lupartumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99718/Lupartumab-SDS-MedChemExpress.pdf
Clinical Information
Phase 1
CAS Number
1640971-88-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS719425-01 0.05 mg
Rabbit anti-human Nuclear factor NF-kappa-B p105 subunit 1 polyclonal Antibody, HRP conjugated
Ask
View Details MBS719425-02 0.1 mg
Rabbit anti-human Nuclear factor NF-kappa-B p105 subunit 1 polyclonal Antibody, HRP conjugated
Ask
View Details MBS719425-03 5x 0.1 mg
Rabbit anti-human Nuclear factor NF-kappa-B p105 subunit 1 polyclonal Antibody, HRP conjugated
Ask
View Details